As of January 2025, Zhejiang CONBA Pharmaceutical has a market cap of $1.66B. This makes Zhejiang CONBA Pharmaceutical the world's 5705th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.72B | -3.56% |
2023 | $1.78B | 6.77% |
2022 | $1.67B | -5.40% |
2021 | $1.76B | 6.16% |
2020 | $1.66B | -23.41% |
2019 | $2.17B | 3.71% |
2018 | $2.09B | -16.12% |
2017 | $2.49B | -3.28% |
2016 | $2.57B | -17.93% |
2015 | $3.14B | 50.51% |
2014 | $2.08B | 11.70% |
2013 | $1.87B | 38.56% |
2012 | $1.35B | 37.91% |
2011 | $976.64M | -30.28% |
2010 | $1.40B | 63.29% |
2009 | $857.84M | 129.58% |
2008 | $373.66M | -56.17% |
2007 | $852.62M | 171.31% |
2006 | $314.27M | 45.73% |
2005 | $215.65M | 0.93% |
2004 | $213.66M | - |